BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38548013)

  • 1. Human β-defensins and their synthetic analogs: Natural defenders and prospective new drugs of oral health.
    Chen M; Hu Z; Shi J; Xie Z
    Life Sci; 2024 Jun; 346():122591. PubMed ID: 38548013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Host Defense Peptide Human β-defensins in the Maintenance of Skin Barriers.
    Kiatsurayanon C; Ogawa H; Niyonsaba F
    Curr Pharm Des; 2018; 24(10):1092-1099. PubMed ID: 29589537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and regulation of defensins in host defense.
    Fu J; Zong X; Jin M; Min J; Wang F; Wang Y
    Signal Transduct Target Ther; 2023 Aug; 8(1):300. PubMed ID: 37574471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial antimicrobial peptides: review and significance for oral applications.
    Weinberg A; Krisanaprakornkit S; Dale BA
    Crit Rev Oral Biol Med; 1998; 9(4):399-414. PubMed ID: 9825219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defensins: defenders of human reproductive health.
    Zhai YJ; Feng Y; Ma X; Ma F
    Hum Reprod Update; 2023 Jan; 29(1):126-154. PubMed ID: 36130055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human β-Defensins in Diagnosis of Head and Neck Cancers.
    Kompuinen J; Keskin M; Yilmaz D; Gürsoy M; Gürsoy UK
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insights into the role of human β-defensins in atopic dermatitis.
    Chieosilapatham P; Ogawa H; Niyonsaba F
    Clin Exp Immunol; 2017 Nov; 190(2):155-166. PubMed ID: 28708318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.
    Scudiero O; Galdiero S; Cantisani M; Di Noto R; Vitiello M; Galdiero M; Naclerio G; Cassiman JJ; Pedone C; Castaldo G; Salvatore F
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2312-22. PubMed ID: 20308372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines.
    Scudiero O; Galdiero S; Nigro E; Del Vecchio L; Di Noto R; Cantisani M; Colavita I; Galdiero M; Cassiman JJ; Daniele A; Pedone C; Salvatore F
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1701-8. PubMed ID: 23357761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of human β-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.
    Sharma H; Nagaraj R
    Peptides; 2012 Dec; 38(2):255-65. PubMed ID: 23000475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of human beta-defensins in HIV infection.
    Weinberg A; Quiñones-Mateu ME; Lederman MM
    Adv Dent Res; 2006 Apr; 19(1):42-8. PubMed ID: 16672548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Toll-like receptor 2 in mediating the production of cytokines and human beta-defensins in oral mucosal epithelial cell response to Leptospiral infection.
    Inthasin N; Wongprompitak P; Boonwong C; Ekpo P
    Asian Pac J Allergy Immunol; 2019 Dec; 37(4):198-204. PubMed ID: 30118246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases.
    Komatsuzawa H; Ouhara K; Kawai T; Yamada S; Fujiwara T; Shiba H; Kurihara H; Taubman MA; Sugai M
    Curr Pharm Des; 2007; 13(30):3084-95. PubMed ID: 17979751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defensins in saliva and the salivary glands.
    Abiko Y; Nishimura M; Kaku T
    Med Electron Microsc; 2003 Dec; 36(4):247-52. PubMed ID: 16228657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial and neutralizing effect of human β-defensins on Enterococcus faecalis and Enterococcus faecalis lipoteichoic acid.
    Lee SH; Baek DH
    J Endod; 2012 Mar; 38(3):351-6. PubMed ID: 22341073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of a linear inactive analog of human β-defensin 4 to generate peptides with potent antimicrobial activity.
    Sharma H; Mathew B; Nagaraj R
    J Pept Sci; 2015 Jun; 21(6):501-11. PubMed ID: 25810238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human β-defensins are correlated with the immune infiltration and regulated by vitamin D
    Zhang C; Han Y; Miao L; Yue Z; Xu M; Liu K; Hou J
    J Periodontal Res; 2023 Oct; 58(5):986-996. PubMed ID: 37439265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human β-defensin 4 - defensin without the "twist".
    Prahl A; Pazgier M; Alexandratos J; Lubkowski J
    Postepy Biochem; 2016; 62(3):349-361. PubMed ID: 28132490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum and human beta-defensins modulate the release of antimicrobial chemokine CCL20/macrophage inflammatory protein 3α.
    Ghosh SK; Gupta S; Jiang B; Weinberg A
    Infect Immun; 2011 Nov; 79(11):4578-87. PubMed ID: 21911466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of hBDs in the gingival tissue and keratinocytes from healthy subjects and periodontitis patients.
    Liu J; Chen J; Du X; Hu L; Chen L
    Arch Oral Biol; 2014 Feb; 59(2):193-8. PubMed ID: 24370191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.